EFFECT OF ADDITION OF GENICULAR NERVE BLOCKS TO ADDUCTOR CANAL BLOCKS AND I-PACK BLOCKS IN TOTAL KNEE ARTHROPLASTY PATIENTS.
- Conditions
- Medical and Surgical,
- Registration Number
- CTRI/2023/07/054783
- Lead Sponsor
- NORTHERN RAILWAY CENTRAL HOSPITAL
- Brief Summary
Patients will be categorised into 2 groups- Group A-patients receiving Genicular nerve blocks in addition to standard Adductor canal blocks and
I-PACKS. Group B-patients receiving only adductor canal blocks(ACBs) +I-PACKS.
On the day of surgery, in all patients, routine spinal anesthesia using 12.5mg(2.5ml) hyperbaric bupivcaine will be given.After confirming the hemodynamic stability of the patients, patients in the 2 groups will undergo blocks using ultrasound as follows: All patients will receive I-PACK blocks using 15ml of 0.375% Ropivacaine and Adductor canal block catheter will be placed( infusion of 0.25% ropivacaine will be started only after the surgery at the rate of 4ml/hr).These will be placed using standard protocols.
In addition one group will receive Genicular nerve blocks using 0.5% ropivacaine( 2ml each for the superolateral, superomedial, inferomedial genicular nerves).
At the end of surgery patient will be shifted to PACU, where the continuous ACB infusion will be started.
A standardised protocol of oral paracetamol 650mg 6hourly and injection diclofenac 50mg will be given 12hourly.
Those patients who reported pain score(NRS> EQUAL TO 4) will be randomised to receive rescue analgesia which will be one of the following- morphine 10mg=buprenorphine 0.4mg=butorphanol 2mg=nalbuphine 10 mg.
At the end of 24hrs, total rescue analgesia given will be calculated in morphine equivalents.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 58
ASA GRADE 1-3 BMI-18 TO 35 KG/M2 SCHEDULED FOR PRIMARY TOTAL KNEE ARTHROPLASTY SURGERY.
Known allergy or intolerance to ropivacaine , bupivacaine or other local anaesthetics Contraindication to peripheral nerve block(eg- local infection, neurologic deficit or disorder, previous trauma or surgery of ipsilateral knee, etc.) Any history of chronic pain Chronic opioid consumption(daily morphine equivalent of >30 mg for at least four weeks prior to surgery) Receiving general anaesthesia Hepatic or renal insufficiency History of psychiatric disorder History of Epilepsy or Seizure disorder significant coagulopathy (platelet count <75000/ml or international normalized ratio >1.5) Revision surgery.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total morphine equivalents given to the patient over and above the standard pain analgesia protocol in patients undergoing total knee replacement surgery. 24 hours
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
NORTHERN RAILWAY CENTRAL HOSPITAL
🇮🇳Central, DELHI, India
NORTHERN RAILWAY CENTRAL HOSPITAL🇮🇳Central, DELHI, IndiaDR SONAXI DASPrincipal investigator8249477429sonaxidas11@gmail.com